Generic Name
Lymecycline
Chemical Class
Tetracycline-class broad-spectrum antibiotic
It is the ethylenediamine salt of tetracycline, more water-soluble and better absorbed orally than tetracycline itself
Brand Names
Tetralysal
Lymecycline Actavis
Lymecycline Almus
Lymecycline Sandoz
Lymecycline Tillomed
Other international brands include Gramalyn, Mekocycline, and Demeclocine
Drug Class
Antibacterial
Tetracycline-class antibiotic
Bacteriostatic protein synthesis inhibitor
Mechanism of Action
Lymecycline inhibits bacterial protein synthesis by reversibly binding to the 30S ribosomal subunit
This blocks the attachment of aminoacyl-tRNA to the mRNA-ribosome complex
The result is inhibition of bacterial protein synthesis and suppression of bacterial growth
It exhibits bacteriostatic activity against many Gram-positive and Gram-negative organisms
Also effective against some atypical organisms like Chlamydia, Mycoplasma, Rickettsia, and Propionibacterium acnes (now Cutibacterium acnes)
Spectrum of Activity
Gram-positive bacteria: Staphylococcus aureus (including some MRSA), Streptococcus spp.
Gram-negative bacteria: Haemophilus influenzae, Escherichia coli, Neisseria gonorrhoeae, Yersinia pestis
Atypical: Chlamydia trachomatis, Mycoplasma pneumoniae, Rickettsia spp., Borrelia burgdorferi
Anaerobes: limited activity
Protozoa: some efficacy against Plasmodium spp.
Resistance may be mediated via efflux pumps or ribosomal protection proteins
Indications
Licensed Uses
Acne vulgaris (moderate to severe inflammatory acne)
Respiratory tract infections
Urinary tract infections
Sexually transmitted infections (e.g., Chlamydia)
Rickettsial infections
Prophylaxis of malaria (off-label or in select guidelines)
Skin and soft tissue infections
Brucellosis (in combination therapy)
Off-Label Uses
Rosacea (anti-inflammatory, not curative)
Lyme disease (alternative when doxycycline is unavailable)
Pelvic inflammatory disease (part of combination therapy)
Traveler’s diarrhea (less commonly than doxycycline)
Dosage and Administration
Standard Dose (Adults and Children ≥12 years)
300 mg to 408 mg once daily orally
Often 408 mg (equivalent to ~300 mg tetracycline base) is used for acne
Alternative Dosage in Infections
408 mg twice daily in severe infections (based on clinical need)
Duration depends on the site and severity of infection
Acne vulgaris
408 mg once daily for 8–12 weeks
May be extended up to 6 months depending on response and physician discretion
Topical agents (e.g., benzoyl peroxide, retinoids) often co-prescribed
Pediatric Use
Not recommended for children under 12 years of age
Contraindicated due to risk of permanent tooth discoloration and enamel hypoplasia
Renal Impairment
Dose adjustment generally not required in mild-moderate impairment
Caution advised in severe impairment due to tetracycline class renal handling
Administration Notes
Take with a full glass of water to prevent esophageal irritation
Preferably taken on an empty stomach, but can be taken with food if gastric upset occurs
Avoid taking concurrently with milk, antacids, iron, calcium, or magnesium supplements (reduced absorption)
Pharmacokinetics
Absorption
Rapid oral absorption
Bioavailability: ~100%
Peak plasma concentration: 2–3 hours post-dose
Distribution
Widely distributed throughout body tissues
Crosses placenta and enters breast milk
Crosses blood-brain barrier (low CNS levels)
Metabolism
Minimal hepatic metabolism
Elimination
Excreted primarily unchanged in urine and feces
Elimination half-life: ~8–10 hours
Prolonged in renal impairment
Contraindications
Hypersensitivity to tetracyclines
Children under 12 years
Pregnancy (due to risk of fetal teeth and bone development issues)
Breastfeeding (excreted in breast milk and affects dental development)
Severe hepatic failure (use with caution)
Warnings and Precautions
Photosensitivity
Patients may develop exaggerated sunburn reactions
Advise to avoid direct sunlight or tanning beds
Use protective clothing and broad-spectrum sunscreen
Esophageal Irritation and Ulceration
Instruct patients to take with sufficient water and remain upright for at least 30 minutes
Superinfections
Prolonged use may cause fungal or resistant bacterial overgrowth
Candidiasis, enterocolitis, or Clostridioides difficile-associated diarrhea (CDAD) possible
Hepatotoxicity
Rarely causes hepatic dysfunction
Monitor liver function tests in prolonged use or pre-existing liver disease
Benign Intracranial Hypertension (Pseudotumor Cerebri)
Occurs mostly in females of childbearing age
Symptoms: headache, visual changes, papilledema
Discontinue if suspected
Skeletal Effects
Binds to calcium, may affect fetal bone growth or infant tooth development
Avoid during pregnancy and lactation
Pregnancy and Lactation
Pregnancy
Category D (US)
Avoid throughout pregnancy
Risk of permanent tooth discoloration and inhibition of bone growth
Lactation
Excreted in breast milk
Not recommended due to risk of dental enamel hypoplasia and growth inhibition in the infant
Adverse Effects
Very Common
Nausea
Abdominal pain
Headache
Common
Vomiting
Diarrhea
Photosensitivity
Dizziness
Rash
Fatigue
Less Common
Benign intracranial hypertension
Esophagitis
Candidiasis (oral or vaginal)
Liver enzyme elevation
Skin hyperpigmentation
Rare
Hypersensitivity reactions (urticaria, angioedema, anaphylaxis)
Erythema multiforme, Stevens-Johnson syndrome
Hepatitis
Renal impairment (Fanconi syndrome in outdated tetracyclines)
Pancreatitis
Overdose
Symptoms include GI irritation, vomiting, and rarely liver or renal injury
Treatment is supportive; no specific antidote
Hemodialysis not effective due to high protein binding
Drug Interactions
Cation-containing compounds (calcium, magnesium, aluminum, iron, zinc)
Chelation reduces lymecycline absorption
Separate administration by at least 2 hours
Oral contraceptives
Tetracyclines may reduce effectiveness through gut flora disruption
Advise additional contraceptive methods during treatment
Anticoagulants (e.g., warfarin)
Potentiation of anticoagulant effect
Monitor INR closely
Retinoids (e.g., isotretinoin)
Increased risk of intracranial hypertension
Avoid concomitant use
Penicillins
Antagonistic antibacterial effect (tetracyclines are bacteriostatic, penicillins are bactericidal)
Avoid combining when treating serious infections
Methoxyflurane
Concurrent use may result in fatal nephrotoxicity
Contraindicated
Use in Special Populations
Children under 12 years
Contraindicated due to effects on teeth and bones
Elderly
No specific precautions
Use normal adult dose unless renal or hepatic impairment exists
Renal Impairment
Mild/moderate: no dose adjustment
Severe: use with caution; monitor renal function
Hepatic Impairment
Caution advised
Avoid in severe hepatic failure
Monitoring Parameters
Clinical response (improvement of acne or infection)
Signs of superinfection (e.g., candidiasis, diarrhea)
Liver and renal function if treatment exceeds 2–3 weeks
Signs of photosensitivity
Visual disturbances suggestive of intracranial hypertension
Comparative Pharmacology
Lymecycline vs Doxycycline
Doxycycline has longer half-life and once-daily dosing
Doxycycline more commonly used in systemic infections
Lymecycline is better tolerated in acne treatment with fewer GI side effects
Lymecycline vs Minocycline
Minocycline penetrates sebaceous glands better
Minocycline associated with more serious side effects (e.g., lupus-like syndrome, pigmentation)
Lymecycline preferred for tolerability
Lymecycline vs Tetracycline
Lymecycline has superior oral bioavailability and less frequent dosing
Better GI tolerance than tetracycline
Legal and Regulatory Status
Prescription-only medication in most countries
Not listed in WHO Model List of Essential Medicines
Included in several national formularies for acne and bacterial infections
No comments:
Post a Comment